SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation has announced high-throughput, TaqMan® reagent-based genotyping on BioMark™ 48.48 Dynamic Arrays, integrated fluidic circuits (IFCs) for life science research. Until now, large genotyping studies utilizing the gold-standard chemistry have typically required numerous microwell plates, dispensing robotics to handle the intensive liquid handling, and large amounts of costly reagents. This approach, while automated, is prohibitively complex and expensive. BioMark dynamic arrays radically simplify the process because their matrixed network of channels, valves, and chambers automatically assembles 2,304 parallel, nano-volume reactions on each IFC. With the BioMark™ system and standard, industry-accepted reagents, researchers can increase their throughput 6-fold, decrease pipetting 50-fold, and, yet, cut running costs substantially relative to current 384-well genotyping systems.
